Acer Therapeutics Inc.

NASDAQ: ACER · Real-Time Price · USD
0.66
-0.14 (-17.96%)
At close: Nov 20, 2023, 9:59 PM

Acer Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Revenue
n/a 1.26M
Cost of Revenue
n/a n/a
Gross Profit
n/a 1.26M
Operating Income
-24.61M -15.95M
Interest Income
1.82K 49.27
Pretax Income
-26.24M -15.37M
Net Income
-26.24M -15.37M
Selling & General & Admin
12.69M 10.7M
Research & Development
11.93M 6.51M
Other Expenses
n/a n/a
Operating Expenses
24.61M 17.21M
Interest Expense
101.43K n/a
Selling & Marketing Expenses
n/a n/a
Cost & Expenses
24.61M 17.21M
Income Tax Expense
1.62M -645K
Shares Outstanding (Basic)
15.77M 14.27M
Shares Outstanding (Diluted)
15.77M 14.27M
EPS (Basic)
-1.77 -1.03
EPS (Diluted)
-1.77 -1.03
EBITDA
-24.55M -15.88M
EBIT
-26.14M -15.95M
Depreciation & Amortization
-198K -54.76K